title: The effects of pituitary adenylate cyclase-activating polypeptide on acute and chronic morphine actions in mice.
abstract: The effects of pituitary adenylate cyclase-activating polypeptide (PACAP) on pain sensitivity, on morphine analgesia, on morphine tolerance and withdrawal were investigated in mice. The heat-radiant tail-flick test was used to assess antinociceptive threshold. Intracerebroventricular (i.c.v.) administration of PACAP alone had no effect on pain sensitivity but in a dose of 500 ng, it significantly diminished the analgesic effect of a single dose of morphine (2.25 mg/kg, s.c.). PACAP (500 ng, i.c.v.) significantly increased the chronic tolerance to morphine and enhanced the naloxone (1 mg/kg, s.c.)-precipitated withdrawal jumping. Theophylline (1 mg/kg, i.p.) pretreatment significantly enhanced the effect of PACAP on morphine analgesia but the effects of PACAP on tolerance and withdrawal were unaffected upon theophylline administration. On the grounds of our previous studies with vasoactive intestinal polypeptide (VIP), it appears that different receptors are involved in the effects of PACAP in acute and chronic morphine actions. Our results indicate that PACAP-induced actions likely participate in acute and chronic effects of morphine and suggest a potential role of PACAP in opioid analgesia, tolerance and withdrawal.
authors.affiliation: Department of Pathophysiology, Albert Szent-Györgyi Medical and Pharmaceutical Center, University of Szeged, Hungary.
authors.forename: Mónika
authors.initials: M
authors.lastname: Mácsai
authors.forename: Imre
authors.initials: I
authors.lastname: Pataki
authors.forename: Gábor
authors.initials: G
authors.lastname: Tóth
authors.forename: Gyula
authors.initials: G
authors.lastname: Szabó
mesh_terms: D000700:Analgesics / Q000494:pharmacology*; D000818:Animals; D004357:Drug Synergism; D004361:Drug Tolerance; D008297:Male; D051379:Mice; D009020:Morphine / Q000494:pharmacology*; D009479:Neuropeptides / Q000008:administration & dosage / Q000494:pharmacology*; D017288:Pain Threshold / Q000187:drug effects*; D051219:Pituitary Adenylate Cyclase-Activating Polypeptide; D013375:Substance Withdrawal Syndrome; D013997:Time Factors
chemical_list: C495402:Adcyap1 protein, mouse; D000700:Analgesics; D009479:Neuropeptides; D051219:Pituitary Adenylate Cyclase-Activating Polypeptide; D009020:Morphine